Oral rivaroxaban for Japanese patients with symptomatic venous thromboembolism - the J-EINSTEIN DVT and PE program (vol 13, 2, 2015)

被引:0
|
作者
Yamada, Norikazu [1 ]
Hirayama, Atsushi [2 ]
Maeda, Hideaki [3 ]
Sakagami, Satoru [4 ]
Shikata, Hiroo [5 ]
Prins, Martin H. [6 ]
Lensing, Anthonie W. A. [7 ]
Kato, Masaharu [8 ]
Onuma, Junichi [8 ]
Miyamoto, Yuki [8 ]
Iekushi, Kazuma [8 ]
Kajikawa, Mariko [8 ]
机构
[1] Mie Univ, Grad Sch Med, Dept Cardiol & Nephrol, Tsu, Mie, Japan
[2] Nihon Univ, Sch Med, Dept Med, Div Cardiol, Tokyo, Japan
[3] Nihon Univ, Sch Med, Div Cardiovasc Resp & Gen Surg, Tokyo, Japan
[4] Kanazawa Med Ctr, Natl Hosp Org, Dept Cardiol, Kanazawa, Ishikawa, Japan
[5] Kanazawa Med Univ, Dept Cardiovasc Surg, Kanazawa, Ishikawa, Japan
[6] Maastricht Univ, Med Ctr, NL-6200 MD Maastricht, Netherlands
[7] Bayer HealthCare Pharmaceut, Wuppertal, Germany
[8] Bayer Yakuhin Ltd, Osaka, Japan
来源
THROMBOSIS JOURNAL | 2016年 / 14卷
关键词
D O I
10.1186/s12959-016-0085-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:2
相关论文
共 28 条
  • [1] Oral rivaroxaban for Japanese patients with symptomatic venous thromboembolism - the J-EINSTEIN DVT and PE program
    Yamada N.
    Hirayama A.
    Maeda H.
    Sakagami S.
    Shikata H.
    Prins M.H.
    Lensing A.W.A.
    Kato M.
    Onuma J.
    Miyamoto Y.
    Iekushi K.
    Kajikawa M.
    Thrombosis Journal, 13 (1)
  • [2] Erratum to: ‘Oral rivaroxaban for Japanese patients with symptomatic venous thromboembolism – the J-EINSTEIN DVT and PE program’
    Norikazu Yamada
    Atsushi Hirayama
    Hideaki Maeda
    Satoru Sakagami
    Hiroo Shikata
    Martin H. Prins
    Anthonie W. A. Lensing
    Masaharu Kato
    Junichi Onuma
    Yuki Miyamoto
    Kazuma Iekushi
    Mariko Kajikawa
    Thrombosis Journal, 14 (1)
  • [3] Oral Rivaroxaban for the Treatment of Symptomatic Venous Thromboembolism: A Pooled Analysis of the EINSTEIN DVT and EINSTEIN PE Studies
    Buller, Harry Roger
    BLOOD, 2012, 120 (21)
  • [4] Shortened length of hospital stay with rivaroxaban in patients with symptomatic venous thromboembolism in Japan: the J-EINSTEIN pulmonary embolism and deep vein thrombosis program
    Matsuo, Hiroshi
    Prins, Martin
    Lensing, Anthonie W. A.
    Fujinuma, Emi Watanabe
    Miyamoto, Yuki
    Kajikawa, Mariko
    CURRENT MEDICAL RESEARCH AND OPINION, 2015, 31 (06) : 1057 - 1061
  • [5] Oral rivaroxaban versus standard therapy for the treatment of symptomatic venous thromboembolism: A pooled analysis of the EINSTEIN-DVT and PE randomized studies
    Prins M.H.
    Lensing A.W.A.
    Bauersachs R.
    van Bellen B.
    Bounameaux H.
    Brighton T.A.
    Cohen A.T.
    Davidson B.L.
    Decousus H.
    Raskob G.E.
    Berkowitz S.D.
    Wells P.S.
    Thrombosis Journal, 11 (1)
  • [6] Use of Prestudy Heparin Did Not Influence the Efficacy and Safety of Rivaroxaban in Patients Treated for Symptomatic Venous Thromboembolism in the EINSTEIN DVT and EINSTEIN PE Studies
    Prandoni, Paolo
    Prins, Martin H.
    Cohen, Alexander T.
    Mueller, Katharina
    Pap, Akos F.
    Tewes, Miriam C.
    Lensing, Anthonie W. A.
    ACADEMIC EMERGENCY MEDICINE, 2015, 22 (02) : 143 - 149
  • [7] RIVAROXABAN FOR THE TREATMENT OF SYMPTOMATIC VENOUS THROMBOEMBOLISM: IS THERE A NEED FOR INITIAL HEPARIN TREATMENT? A SUBGROUP ANALYSIS OF THE EINSTEIN DVT AND PE STUDIES
    Lensing, Anthonie W. A.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (12) : A2093 - A2093
  • [8] Oral Rivaroxaban for the Acute and Continued Treatment of Symptomatic Venous Thromboembolism. the Einstein-DVT and Einstein-Extension Study
    Buller, Harry Roger
    BLOOD, 2010, 116 (21) : 86 - 86
  • [9] Oral rivaroxaban versus enoxaparin with vitamin K antagonist for the treatment of symptomatic venous thromboembolism in patients with cancer (EINSTEIN-DVT and EINSTEIN-PE): a pooled subgroup analysis of two randomised controlled trials
    Prins, Martin H.
    Lensing, Anthonie W. A.
    Brighton, Tim A.
    Lyons, Roger M.
    Rehm, Jeffrey
    Trajanovic, Mila
    Davidson, Bruce L.
    Beyer-Westendorf, Jan
    Pap, Akos F.
    Berkowitz, Scott D.
    Cohen, Alexander T.
    Kovacs, Michael J.
    Wells, Philip S.
    Prandoni, Paolo
    LANCET HAEMATOLOGY, 2014, 1 (01): : E37 - E46
  • [10] Incidence of recurrent venous thromboembolism in patients following completion of the EINSTEIN DVT and EINSTEIN PE studies
    Prins, M. H.
    Erkens, P. G. M.
    Lensing, A. W. A.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 257 - 257